These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. [Possibilities and limits of oral diabetes therapy]. Bruneder H Wien Med Wochenschr; 1985 Apr; 135(6-7):147-51. PubMed ID: 3890376 [No Abstract] [Full Text] [Related]
11. Biguanides. Mode of action and role in the up-to-date treatment of diabetes mellitus. Fövényi J Ther Hung; 1971; 19(2):43-8. PubMed ID: 5172874 [No Abstract] [Full Text] [Related]
13. [Evaluation of a new sulfonylurea, glipizide, in the treatment of diabetes mellitus]. Ninni M; Castelletta L Minerva Med; 1973 Oct; 64(71):3725-31. PubMed ID: 4588364 [No Abstract] [Full Text] [Related]
14. Editorial: Oral therapy in diabetes mellitus. Scoville AB South Med J; 1974 Jun; 67(6):635-8. PubMed ID: 4208385 [No Abstract] [Full Text] [Related]
15. Oral hypoglycemic agents in type II diabetes mellitus. Lubbos H; Miller JL; Rose LI Am Fam Physician; 1995 Nov; 52(7):2075-8. PubMed ID: 7484707 [TBL] [Abstract][Full Text] [Related]
16. [Oral antidiabetic agents: what are the choices?]. Crausaz FM Rev Med Suisse Romande; 1991 Aug; 111(8):701-5. PubMed ID: 1925244 [No Abstract] [Full Text] [Related]
17. [The use of oral antidiabetics]. Kangas T Duodecim; 1974; 90(4):282-94. PubMed ID: 4603906 [No Abstract] [Full Text] [Related]
18. [On the indication and practical use of oral antidiabetics]. Fankhauser S Schweiz Med Wochenschr; 1972 Jun; 102(24):856-62. PubMed ID: 5033624 [No Abstract] [Full Text] [Related]
19. Influence of glycemic control on the development of diabetic cardiovascular and kidney disease. Saha SA; Tuttle KR Cardiol Clin; 2010 Aug; 28(3):497-516. PubMed ID: 20621253 [TBL] [Abstract][Full Text] [Related]